BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $13.51 Million Stock Position in Colgate-Palmolive (NYSE:CL)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 14.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 148,649 shares of the company's stock after acquiring an additional 18,595 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in Colgate-Palmolive were worth $13,514,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CL. Axxcess Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 0.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock worth $3,526,000 after buying an additional 117 shares during the last quarter. Commonwealth Financial Services LLC grew its holdings in Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after acquiring an additional 118 shares during the period. Wescott Financial Advisory Group LLC grew its holdings in Colgate-Palmolive by 3.5% during the 4th quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock worth $320,000 after acquiring an additional 119 shares during the period. D Orazio & Associates Inc. raised its position in shares of Colgate-Palmolive by 4.2% during the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock valued at $271,000 after acquiring an additional 120 shares during the last quarter. Finally, Lantz Financial LLC lifted its stake in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock valued at $1,831,000 after purchasing an additional 122 shares during the period. Institutional investors own 80.41% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CL. Wells Fargo & Company upped their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. Morgan Stanley lowered their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reissued a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $102.12.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $0.31 on Wednesday, reaching $92.12. 1,829,654 shares of the stock were exchanged, compared to its average volume of 4,672,194. The firm's 50 day moving average is $91.90 and its 200-day moving average is $91.25. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm has a market cap of $74.66 billion, a PE ratio of 26.16, a P/E/G ratio of 4.20 and a beta of 0.39.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter in the prior year, the business earned $0.86 earnings per share. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend was Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive declared that its Board of Directors has initiated a stock buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.